EXHIBIT 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Autonomix Medical, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price (1), (2),(3) |
Fee Rate |
Amount of Registration Fee |
|||||||||||||||||||||
|
Fees to be paid |
Equity |
Common Stock Units, each unit consisting of (i) one share of common stock, par value $0.001 per share and (ii) one warrant to purchase one share of common stock (“Series A Warrant”)(3) |
457 |
(o) |
-- |
-- |
$ |
11,500,000 |
0.00015310 |
$ |
1,760.65 |
|||||||||||||||||
|
Equity |
Pre-Funded Warrant Units, each unit consisting of (i) one pre-funded warrant to purchase one share of common stock (“Pre-Funded Warrant”), and (ii) one Series A Warrant (3) |
457 |
(o) |
-- |
-- |
(a) |
-- |
-- |
||||||||||||||||||||
|
Equity |
Common Stock included in Common Stock Units (4) |
-- |
-- |
-- |
Included above. |
-- |
-- |
|||||||||||||||||||||
|
Equity |
Pre-Funded Warrants included in the Pre-Funded Warrant Units |
-- |
-- |
-- |
$ |
-- |
(5) |
-- |
-- |
|||||||||||||||||||
|
Equity |
Common Stock Underlying Series A Warrants |
457 |
(o) |
-- |
-- |
$ |
13,225,000 |
0.00015310 |
$ |
2,024.748 |
||||||||||||||||||
|
Equity |
Common Stock Underlying Pre-Funded Warrants (4) |
457 |
(o) |
-- |
-- |
Included above. |
-- |
-- |
||||||||||||||||||||
|
Equity |
Representative Warrants (6) |
457 |
(g) |
-- |
-- |
$ |
-- |
(4) |
-- |
-- |
||||||||||||||||||
|
Equity |
Common Stock Underlying Representative Warrants (6) |
457 |
(o) |
-- |
-- |
$ |
1,069,500 |
0.00015310 |
$ |
163.741 |
||||||||||||||||||
|
Total Offering Amounts |
$ |
25,794,500 |
0.00015310 |
$ |
3,949.14 |
|||||||||||||||||||||||
|
Total Fees Previously Paid |
-- |
-- |
$ |
-- |
||||||||||||||||||||||||
|
Net Fee Due |
$ |
3,949.14 |
||||||||||||||||||||||||||
(a) The proposed maximum offering price of the Common Stock Units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrant Units offered and sold in the offering, and as such the proposed aggregate maximum offering price of the Common Stock Units together with the Pre-Funded Warrant Units (including the common stock issuable upon exercise of the Pre-Funded Warrants), if any, is $11,500,000. The registrant may issue Pre-Funded Warrants to purchase shares of common stock in the offering. The purchase price of Pre-Funded Warrant Units will equal the price per unit at which Common Stock Units are being sold to the public in this offering, minus the exercise price for the Pre-Funded Warrants.
|
(1) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
|
|
|
|
(2) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers such an indeterminate amount of shares of common stock as may become issuable to prevent dilution resulting from stock splits, stock dividends and similar events. |
|
|
|
|
(3) |
Includes Units that may be purchased by the underwriters pursuant to their option to purchase additional Units to cover over-allotments. |
|
|
|
|
(4) |
No separate fee is required pursuant to Rule 457(g) under the Securities Act. |
|
|
|
|
(5) |
Consistent with the response to Question 240.06 of the Securities Act Rules Compliance and Disclosure Interpretations, the registration fee with respect to the Series A Warrants included in the units and Pre-Funded Warrant Units, as well as the Pre-Funded Warrants included in the Pre-Funded Units, has been allocated to the shares of common stock underlying such warrants, and those shares of common stock are included in the registration fee as calculated herein. |
|
|
|
|
(6) |
We have agreed to grant to the underwriter a warrant covering a number of shares of common stock equal to 6% of the aggregate number of Common Stock Units and Pre-Funded Warrant Units (including any sold as a result of the exercise of the underwriters’ over-allotment option) (the “Representative Warrant”). The Representative Warrants will be exercisable at any time and from time to time, in whole or in part, during the four- and one-half year period commencing 180 days following the commencement of sales of the securities issued in this offering. The Representative Warrant will be exercisable at a price equal to 155% of the public offering price. We have registered the Representative Warrant and the shares underlying the Representative Warrant in this offering. Accordingly, as estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o), the proposed maximum aggregate offering price of the common stock underlying the Representative Warrant is $1,069,500, which is equal to 155% of $690,000 (6% of $11,500,000, which is the proposed maximum aggregate offering price of the Common Stock Units and Pre-Funded Warrant Units. |